Literature DB >> 13869404

[The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

W BIRKMAYER, O HORNYKIEWICZ.   

Abstract

Entities:  

Keywords:  DOPA/therapy; PARALYSIS AGITANS/therapy

Mesh：

Substances：

Year:  1961        PMID： 13869404

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  180 in total

1.  Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase enhance dopamine delivery after L-3, 4-dihydroxyphenylalanine administration in Parkinsonian rats.

Authors:  W Y Lee; J W Chang; N L Nemeth; U J Kang
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

2.  The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil.

Authors:  W Birkmayer; P Riederer; M B Youdim; W Linauer
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

3.  Editorial: Long-term assessment of levodopa therapy in Parkinson's disease.

Authors:  A Barbeau
Journal:  Can Med Assoc J       Date:  1975-06-21       Impact factor: 8.262

4.  Use of siRNA in knocking down of dopamine receptors, a possible therapeutic option in neuropsychiatric disorders.

Authors:  Mohammad-Reza Noori-Daloii; Majid Mojarrad; Ali Rashidi-Nezhad; Majid Kheirollahi; Ali Shahbazi; Mehdi Khaksari; Asghar Korzebor; Ali Goodarzi; Maryam Ebrahimi; Ali Reza Noori-Daloii
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

5.  [THE EFFICACY OF L-DOPA IN PARKINSON PATIENTS WITH AND WITHOUT STEREOTACTIC BRAIN SURGERY].

Authors:  W UMBACH; D BAUMANN
Journal:  Arch Psychiatr Nervenkr       Date:  1964-06-01

6.  [ADDITIONAL EXPERIMENTAL STUDIES ON L-DOPA IN PARKINSON'S SYNDROME AND RESERPINE PARKINSONISM].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Arch Psychiatr Nervenkr       Date:  1964-12-02

7.  [AUTONOMIC REGULATION DISTURBANCES IN PATIENTS RECOVERING FROM ENCEPHALITIS].

Authors:  W BIRKMAYER
Journal:  Acta Neuroveg (Wien)       Date:  1964-10-02

8.  Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms.

Authors:  Christian Pifl; Stephen J Kish; Oleh Hornykiewicz
Journal:  Mov Disord       Date:  2012-10-04       Impact factor: 10.338

Review 9.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

10.  Dopamine/L-dopa ratio in cerebrospinal fluid of parkinsonian patients treated with L-dopa + benserazide.

Authors:  M Fekete; M Tárczy; K Bihari; G Katona
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.